by Kathy Jones on  September 8, 2013 at 8:10 PM Drug News
 Research Sheds Light on Why Shuyusan can Treat Corticosterone-Induced Impairment
Previous research has highlighted that synthetic antidepressants present a narrow spectrum and side effects following long-term application.

Recently, medical practitioners have shown interest in the use of Chinese medicines for the treatment of diseases and in the adjustment of the human response to stress.

Liping Chen and colleagues from Hainan Branch of Chinese PLA General Hospital have found in their preliminary studies that the Chinese herb Shuyusan, whose main constituent is jasminoidin, has been shown to protect SH-SY5Y cells against corticosterone-induced damage. A recent study reported in the Neural Regeneration Research (Vol. 8, No. 22, 2013) showed that 5 and 30 μg/mL Shuyusan-containing serum elevated the survival rate of SH-SY5Y cells, reduced Bax expression, increased Bcl-2 expression, markedly elevated brain-derived neurotrophic factor mRNA expression, and blocked cell apoptosis. Moreover, the effect of high-dose (30 μg/mL) Shuyusan-containing serum was more remarkable. These findings indicate that Shuyusan-containing serum appears to protect SH-SY5Y cells against corticosterone-induced impairment by adjusting the expression of apoptosis-associated proteins and brain-derived neurotrophic factor.

Source: Eurekalert

Most Popular on Medindia